The deal may value Olive PharmaScience at around ₹ 4,500 crore. MUMBAI Kedaara Capital Investment Managers Ltd is likely to emerge as the
Sneha Shah is a Senior Assistant Editor at various prominent publications. She specializes in new economy businesses, focusing on private and public market funding, startup developments, and investment banking, with a keen interest in finance and investment strategies. Sneha's work has been featured in notable outlets such as Professional Adviser, VCCircle, LiveMint, and The Economic Times, among others.












